• Stable surrogate marker for the kidney stimulating hormone Enkephalin
  • Biomarker that indicates the actual need for kidney stimulation
  • Preceeds the change in serum creatinine by 1-2 days
  • Unaffected by inflammation and co-morbidities

Medical utility

  1. Prediction, diagnosis and close monitoring of Acute Kidney Injury in sepsis, acute heart failure and myocardial infarction
  2. Supports clinical decision-making in:
  • Nephrotoxic drugs
  • Renal Replacement Therapy
  • Hospital discharge

sphingotest® penKid Immunoassay

  • Utilizes a mid-regional fragment of Proenkephalin (penKid) as a stable surrogate marker for Enkephalin
  • sphingotest® penKid Broschure can be downloaded here.